wouldn't worry tech 121 a couple of days ago. commencing human trialsManagement Profile
Mr Brian Leedman – Chairman
Brian Leedman is the Non-executive Chairman and as a biotechnology entrepreneur has co-founded four ASX listed healthcare companies. He is formerly the Chairman of Ausbiotech (WA), the Industry Association of Biotechnology Companies in Australia and holds a BEc and MBA from UWA.
What is your rationale for attending 121 Tech Investment?
InvestorsWhat recent news would you like to highlight to investors attending?
##########Commencing human trials for Alzheimer’s and back of the eye diseases##########
What are your key goals for the next 3, 6 and 12 months?
3 Months:
Commence human studies
6 Months:
Strong recruitment at hospital sites in Australia
12 Months:
Positive results leading to further studies/licencing/partnerships
What do you see as the key risks and challenges facing your company at the moment and how are you overcoming these?
Positive results from Phase I clinical study
In a sentence, what do you think makes your company such a compelling investment?
Our approach to the treatment of Alzheimer’s disease focuses on neurological cell death prevention/rejuvenation rather than Beta-Amyloid plaque removal
